Alfuzosin SR 10mg and Dutasteride 0.5mg 

ALFUGEM D is a specialized medication combining Alfuzosin SR 10mg and Dutasteride 0.5mg, specifically formulated to address the symptoms and underlying causes of benign prostatic hyperplasia (BPH). Manufactured by Steris Pharma, ALFUGEM D offers a synergistic approach to effectively manage BPH-related concerns in men. 

Dual Action for Prostate Health: ALFUGEM D combines the benefits of Alfuzosin SR and Dutasteride to provide comprehensive relief for BPH. Alfuzosin SR 10mg relaxes prostate and bladder muscles, improving urine flow, while Dutasteride 0.5mg reduces prostate size by inhibiting hormone-induced growth. 

Symptom Reduction: ALFUGEM D effectively alleviates BPH symptoms such as frequent urination, nocturia (nighttime urination), weak urine flow, and the sensation of incomplete bladder emptying, leading to improved urinary function and comfort. 

Long-lasting Effectiveness: The sustained-release formulation of Alfuzosin SR in ALFUGEM D ensures continuous symptom relief throughout the day, promoting better bladder control and reducing urgency. 

Prostate Volume Reduction: Dutasteride, a 5-alpha reductase inhibitor, targets the underlying cause of BPH by shrinking the enlarged prostate gland over time, further enhancing urinary flow and reducing the risk of complications. 

The recommended dosage of ALFUGEM D is one tablet (Alfuzosin SR 10mg + Dutasteride 0.5mg) taken orally once daily, preferably with a meal. It is essential to follow the prescribed dosage and administration instructions provided by healthcare professionals for optimal therapeutic outcomes. 

Patients should inform their healthcare providers about any existing medical conditions, allergies, or ongoing medications before starting ALFUGEM D therapy. Regular monitoring of prostate-specific antigen (PSA) levels and prostate health is recommended during ALFUGEM D treatment to assess its efficacy and safety. 

ALFUGEM D offers a comprehensive and targeted approach to managing benign prostatic hyperplasia, combining the muscle-relaxing properties of Alfuzosin SR with the prostate-reducing effects of Dutasteride. By addressing both symptoms and underlying prostate enlargement, ALFUGEM D promotes better urinary function and overall quality of life for individuals with BPH. However, patients should consult healthcare providers for personalized treatment plans and guidance. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology. 

EMAIL: info@sterispharma.com / contact@sterispharma.com 

CALL/WHATSAPP: 7877551268, 7849827488